Volume of the hippocampal subfields in healthy adults: differential associations with age and a pro-inflammatory genetic variant
暂无分享,去创建一个
[1] G. M. Arisi. Nervous and immune systems signals and connections: Cytokines in hippocampus physiology and pathology , 2014, Epilepsy & Behavior.
[2] E. Westman,et al. Regional vulnerability of hippocampal subfields to aging measured by structural and diffusion MRI , 2014, Hippocampus.
[3] Jason P. Lerch,et al. Hippocampal volumes differ across the mouse estrous cycle, can change within 24hours, and associate with cognitive strategies , 2013, NeuroImage.
[4] Jeffrey D. Bernstein,et al. Shared Vulnerability of Two Synaptically-Connected Medial Temporal Lobe Areas to Age and Cognitive Decline: A Seven Tesla Magnetic Resonance Imaging Study , 2013, The Journal of Neuroscience.
[5] L. Fratiglioni,et al. The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age , 2013, Front. Hum. Neurosci..
[6] R. Mortara,et al. Exercise-induced hippocampal anti-inflammatory response in aged rats , 2013, Journal of Neuroinflammation.
[7] S. Bilbo,et al. Chemokines and the hippocampus: A new perspective on hippocampal plasticity and vulnerability , 2013, Brain, Behavior, and Immunity.
[8] P. Calabresi,et al. Effects of central and peripheral inflammation on hippocampal synaptic plasticity , 2013, Neurobiology of Disease.
[9] Christopher A. Hostage,et al. Dissecting the Gene Dose-Effects of the APOE ε4 and ε2 Alleles on Hippocampal Volumes in Aging and Alzheimer’s Disease , 2013, PloS one.
[10] F. Craik,et al. Associative recognition in mild cognitive impairment: Relationship to hippocampal volume and apolipoprotein E , 2012, Neuropsychologia.
[11] Wiro J. Niessen,et al. Vascular risk factors, apolipoprotein E, and hippocampal decline on magnetic resonance imaging over a 10-year follow-up , 2012, Alzheimer's & Dementia.
[12] H. Nakanishi,et al. Age-dependent neuroinflammatory responses and deficits in long-term potentiation in the hippocampus during systemic inflammation , 2012, Neuroscience.
[13] Walter Heindel,et al. Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain , 2012, Journal of Neuroinflammation.
[14] Andrew R. Bender,et al. Age-related differences in memory and executive functions in healthy APOE ɛ4 carriers: The contribution of individual differences in prefrontal volumes and systolic blood pressure , 2012, Neuropsychologia.
[15] B. Mazoyer,et al. Circulating IL-6 and CRP are associated with MRI findings in the elderly , 2012, Neurology.
[16] Naftali Raz,et al. Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants. , 2012, Biochimica et biophysica acta.
[17] Eric D Vidoni,et al. Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging. , 2012, Biochimica et biophysica acta.
[18] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[19] Rodney W. Johnson,et al. Dysregulated neuronal–microglial cross-talk during aging, stress and inflammation , 2012, Experimental Neurology.
[20] P Aspelin,et al. Medial temporal lobe is vulnerable to vascular risk factors in men: a population‐based study , 2012, European journal of neurology.
[21] Wei Li,et al. Role of microglia in CNS inflammation , 2011, FEBS letters.
[22] A. Reiss,et al. Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease , 2011, Neurobiology of Aging.
[23] Günther Deuschl,et al. CA1 neurons in the human hippocampus are critical for autobiographical memory, mental time travel, and autonoetic consciousness , 2011, Proceedings of the National Academy of Sciences.
[24] Menno P. Witter,et al. A pathophysiological framework of hippocampal dysfunction in ageing and disease , 2011, Nature Reviews Neuroscience.
[25] Philip S. Insel,et al. Impact of apolipoprotein ɛ4–cerebrospinal fluid beta-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment , 2011, Alzheimer's & Dementia.
[26] Rebecca Hardy,et al. Life Course Trajectories of Systolic Blood Pressure Using Longitudinal Data from Eight UK Cohorts , 2011, PLoS medicine.
[27] Michael Weiner,et al. Evidence for functional specialization of hippocampal subfields detected by MR subfield volumetry on high resolution images at 4T , 2011, NeuroImage.
[28] Paul M. Thompson,et al. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease , 2011, NeuroImage.
[29] P. Grammas,et al. Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease , 2011, Journal of Neuroinflammation.
[30] Yee Lee Shing,et al. Aging Neuroscience , 2022 .
[31] Inbal Goshen,et al. Immune modulation of learning, memory, neural plasticity and neurogenesis , 2011, Brain, Behavior, and Immunity.
[32] Johannes Kornhuber,et al. Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults , 2011, Journal of Neural Transmission.
[33] Zhenbo Huang,et al. Interleukin-1β with learning and memory , 2010, Neuroscience bulletin.
[34] Carole Dufouil,et al. Effects of ApoE-ɛ4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons , 2010, NeuroImage.
[35] Marine Fouquet,et al. Differential effect of age on hippocampal subfields assessed using a new high-resolution 3T MR sequence , 2010, NeuroImage.
[36] J. Wesson Ashford,et al. Apolipoprotein E ɛ4 influences on episodic recall and brain structures in aging pilots , 2010, Neurobiology of Aging.
[37] Joseph V. Hajnal,et al. A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T) , 2010, NeuroImage.
[38] Mark D'Esposito,et al. Imaging the aging brain , 2009 .
[39] M. Weiner,et al. Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields , 2009, Hippocampus.
[40] D. Amaral,et al. The Hippocampal Formation , 2009 .
[41] Polina Golland,et al. Automated segmentation of hippocampal subfields from ultra‐high resolution in vivo MRI , 2009, Hippocampus.
[42] J. Kriz,et al. Inflammation, plasticity and real-time imaging after cerebral ischemia , 2009, Acta Neuropathologica.
[43] O. Lindvall,et al. Brain inflammation and adult neurogenesis: The dual role of microglia , 2009, Neuroscience.
[44] F. Sutterwala,et al. Sensing pathogens and danger signals by the inflammasome. , 2009, Current opinion in immunology.
[45] Antonella Plaia,et al. Association between the interleukin-1β polymorphisms and Alzheimer's disease: A systematic review and meta-analysis , 2008, Brain Research Reviews.
[46] L. Fañanás,et al. Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin‐1 beta gene (2q13) , 2008, Genes, brain, and behavior.
[47] Ahmad R. Hariri,et al. Interleukin-6 Covaries Inversely with Hippocampal Grey Matter Volume in Middle-Aged Adults , 2008, Biological Psychiatry.
[48] Jae Woong Lee,et al. Journal of Neuroinflammation Neuro-inflammation Induced by Lipopolysaccharide Causes Cognitive Impairment through Enhancement of Beta-amyloid Generation , 2022 .
[49] Kaarin J Anstey,et al. Total and regional gray matter volume is not related to APOE*E4 status in a community sample of middle-aged individuals. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.
[50] George Davey Smith,et al. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.
[51] U. Lindenberger,et al. Neuroanatomical correlates of fluid intelligence in healthy adults and persons with vascular risk factors. , 2008, Cerebral cortex.
[52] Silvia Kochen,et al. Association study between interleukin 1β gene and epileptic disorders: a HuGe review and meta-analysis , 2008, Genetics in Medicine.
[53] J. Koo,et al. IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress , 2008, Proceedings of the National Academy of Sciences.
[54] N. Rothwell,et al. Interleukin-1 and inflammatory neurodegeneration. , 2007, Biochemical Society transactions.
[55] S. Warach,et al. Interleukin-6 −174G/C Polymorphism and Ischemic Stroke: A Systematic Review , 2007, Stroke.
[56] R. Kesner. Behavioral functions of the CA3 subregion of the hippocampus. , 2007, Learning & memory.
[57] A. Mykletun,et al. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study , 2007, BMC public health.
[58] N. Schuff,et al. Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4T , 2007, Neurobiology of Aging.
[59] Edward Reynolds,et al. Vitamin B12, folic acid, and the nervous system , 2006, The Lancet Neurology.
[60] Jonas Persson,et al. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E ɛ4: Relation to chronological age and recognition memory , 2006, Neuroscience Letters.
[61] F. Licastro,et al. Interleukin-1β and interleukin-6 gene polymorphisms as risk factors for AD: A prospective study , 2006, Experimental Gerontology.
[62] Cheryl L. Dahle,et al. Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. , 2005, Cerebral cortex.
[63] C. Jack,et al. Alzheimer's Disease Neuroimaging Initiative , 2008 .
[64] Manuel Desco,et al. Ventricular enlargement in schizophrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene , 2005, NeuroImage.
[65] William A Banks,et al. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. , 2005, Current pharmaceutical design.
[66] Carole Dufouil,et al. No ɛ4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects , 2005, NeuroImage.
[67] Daniel W. Jones,et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. , 2005, Hypertension.
[68] Eileen M. Crimmins,et al. Inflammatory Exposure and Historical Changes in Human Life-Spans , 2004, Science.
[69] E. Green,et al. A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[70] R. Veerhuis,et al. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes , 2004, Aging cell.
[71] Philip Scheltens,et al. Midlife Blood Pressure and the Risk of Hippocampal Atrophy: The Honolulu Asia Aging Study , 2004, Hypertension.
[72] M. B. Katan,et al. Apolipoprotein E isoforms, serum cholesterol, and cancer , 2004 .
[73] C. Lefebvre d’Hellencourt,et al. Dentate gyrus: alterations that occur with hippocampal injury. , 2003, Neurotoxicology.
[74] G. Kolovou,et al. Apolipoprotein E Polymorphism and Atherosclerosis , 2003, Angiology.
[75] Stephen M Smith,et al. Fast robust automated brain extraction , 2002, Human brain mapping.
[76] R. Mrak,et al. Interleukin‐1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer’s disease , 2002, Journal of leukocyte biology.
[77] Jun-tao Guo,et al. Inflammation-Dependent Cerebral Deposition of Serum Amyloid A Protein in a Mouse Model of Amyloidosis , 2002, The Journal of Neuroscience.
[78] B. Mcewen,et al. Volumetric structural magnetic resonance imaging (MRI) of the rat hippocampus following kainic acid (KA) treatment , 2002, Brain Research.
[79] F. Lalonde,et al. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women , 2001, Neurology.
[80] W. Banks,et al. Intravenous human interleukin-1alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum. , 2001, The Journal of pharmacology and experimental therapeutics.
[81] U Hegerl,et al. Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia. , 2001, The American journal of psychiatry.
[82] Jean-Philippe Galons,et al. Quantitative Volumetric Analyses of Brain Magnetic Resonance Imaging from Rat with Chronic Neuroinflammation , 2000, Experimental Neurology.
[83] S. Resnick,et al. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype , 2000, Neurology.
[84] C. Franceschi,et al. Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .
[85] M. Bobinski,et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease , 1999, Neuroscience.
[86] R. Dantzer,et al. Temporal and spatial relationships between lipopolysaccharide-induced expression of fos, interleukin-1 β and inducible nitric oxide synthase in rat brain , 1999, Neuroscience.
[87] Q. Mu,et al. A quantitative MR study of the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle in healthy subjects 40 to 90 years of age. , 1999, AJNR. American journal of neuroradiology.
[88] M. Lynch. Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukin-1β? , 1998, Progress in Neurobiology.
[89] M. Hurme,et al. IL‐1 receptor antagonist (IL‐1Ra) plasma levels are co‐ordinately regulated by both IL‐1Ra and IL‐1β genes , 1998 .
[90] D. Levy,et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. , 1997, Circulation.
[91] A D Roses,et al. Apolipoprotein E and Alzheimer's Disease A Rapidly Expanding Field with Medical and Epidemiological Consequences , 1996, Annals of the New York Academy of Sciences.
[92] J. Morrison,et al. GERIATRIC BIOSCIENCE: Hippocampal and Neocortical Involvement in Normal Brain Aging and Dementia: Morphological and Neurochemical Profile of the Vulnerable Circuits , 1996, Journal of the American Geriatrics Society.
[93] W. Banks,et al. Passage of cytokines across the blood-brain barrier. , 1995, Neuroimmunomodulation.
[94] Daniel H. Mathalon,et al. Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus , 1995, Neurobiology of Aging.
[95] A D Roses,et al. Apolipoprotein E and Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[96] K. Suyama. Changes of Neuronal Transmission in the Hippocampus After Transient Ischemia in Spontaneously Hypertensive Rats and the Protective Effects of MK‐801 , 1992, Stroke.
[97] G. Fillion,et al. Receptors for interleukin-1 (α and β) in mouse brain: Mapping and neuronal localization in hippocampus , 1991, Neuroscience.
[98] R. Mahley,et al. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.
[99] C. Petito,et al. Delayed Neuronal Recovery and Neuronal Death in Rat Hippocampus following Severe Cerebral Ischemia: Possible Relationship to Abnormalities in Neuronal Processes , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[100] F. Plum,et al. Moderate hyperglycemia augments ischemic brain damage , 1982, Neurology.
[101] J. Fleiss,et al. Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.
[102] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[103] Tm Brouwers,et al. VIRUS-INFECTION OF URINARY-TRACT , 1974 .
[104] R. C. Oldfield. The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.
[105] J R Foster,et al. Ageing and the Regulation of Cell Activities during Exposure to Cold , 1969, The Journal of general physiology.
[106] Robert A. Gross,et al. Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study , 2012 .
[107] Agatha D. Lee,et al. Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study. , 2011, Journal of Alzheimer's disease : JAD.
[108] 盛国庆. Interleukin-1beta with learning and memory. , 2011 .
[109] Naftali Raz,et al. A Systems Approach to the Aging Brain: Neuroanatomic Changes, Their Modifiers, and Cognitive Correlates , 2009 .
[110] Carole Dufouil,et al. No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. , 2005, NeuroImage.
[111] A Hofman,et al. Homocysteine and brain atrophy on MRI of non-demented elderly. , 2003, Brain : a journal of neurology.
[112] T. Sugawara,et al. Effects of global ischemia duration on neuronal, astroglial, oligodendroglial, and microglial reactions in the vulnerable hippocampal CA1 subregion in rats. , 2002, Journal of neurotrauma.
[113] N. Raz. Aging of the brain and its impact on cognitive performance: Integration of structural and functional findings. , 2000 .
[114] R. Dantzer,et al. Cytokine signals propagate through the brain , 2000, Molecular Psychiatry.
[115] F. Craik,et al. The handbook of aging and cognition , 1992 .
[116] G. Fillion,et al. Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. , 1991, Neuroscience.
[117] G. Paxinos. The Rat nervous system , 1985 .
[118] L. Radloff. The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .